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Abstract
Adhesion of the human pathogen Neisseria gonorrhoeae has established effects on the host cell and evokes a variety of
cellular events including growth factor activation. In the present study we report that infection with N. gonorrhoeae causes
altered amphiregulin processing and release in human epithelial cells. Amphiregulin is a well-studied growth factor with
functions in various cell processes and is upregulated in different forms cancer and proliferative diseases. The protein is
prototypically cleaved on the cell surface in response to external stimuli. We demonstrate that upon infection, a massive
upregulation of amphiregulin mRNA is seen. The protein changes its subcellular distribution and is also alternatively cleaved
at the plasma membrane, which results in augmented release of an infection-specific 36 kDa amphiregulin product from
the surface of human cervical epithelial cells. Further, using antibodies directed against different domains of the protein we
could determine the impact of infection on pro-peptide processing. In summary, we present data showing that the infection
of N. gonorrhoeae causes an alternative amphiregulin processing, subcellular distribution and release in human epithelial
cervical cells that likely contribute to the predisposition cellular abnormalities and anti-apoptotic features of N. gonorrhoeae
infections.
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Introduction
The human pathogen Neisseria gonorrhoeae (gonococcus), the
causative agent of the sexually transmitted disease gonorrhea,
primarily colonizes the mucosal surface of the male urethra and the
female cervix but also colonizes the vagina, pharynx, rectum and
conjunctiva of theeye.Initial attachment of the bacteria tothe apical
side of epithelial tissues is mediated by type IV pili [1,2,3,4]. The
adherence mediates host cell signaling events and elicits a multitude
of cellular responses, including cortical plaque formation [3], release
of intracellular calcium [5,6] and anti apoptotic factors [7,8].
Also, 24 hours of N. gonorrhoeae infection alters cell cycle
progression by the reduction of cyclin B1 levels in HeLa cells,
causing early G1 arrest [9]. In G1 phase, growth factors, such as
amphiregulin, are active to stimulate cellular growth and cell cycle
progression.
Amphiregulin is a membrane-anchored glycoprotein, belonging to
the epidermal growth factor (EGF) family and promotes a bi-functional
role bystimulating growth of most cell types including normal epithelial
cells as well as malignant cells while at the same time it inhibits the
growth of certain aggressive carcinoma cell lines [10,11,12,13].
Amphiregulin is synthesized as a pro-peptide and cleaved at the
plasma membrane by metalloprotase ADAM17 giving rise to several
different forms of the protein with varying sizes, cellular localizations
and functions [11,14,15], which seems to depend on cell line as well as
external induction of cells and growth conditions [15,16]. The pro-
amphiregulin contains several domains, including the bioactive part
with a heparin binding domain and an EGF like domain, responsible
for binding to the receptor [10]. The action of amphiregulin is
mediated mainly by binding to the epidermal growth factor receptor
(EGFR) also known as ErbB1 or HER1. The binding to the receptor
on its own cell plasma membrane initiates a positive feedback loop of
growth stimulation as well as it initiates a cascade of events leading to
the expression of genes involved in cell cycle progression, cell growth
and apoptosis resistance [17,18,19]. Amphiregulin also has the ability
to directly interact with DNA and heterochromatin, and thereby
potentially alter global gene transcription [10,15].
Amphiregulin is also involved in bacterial infections. Host cell
transcriptional upregulation of amphiregulin occurs in infections
of Shigella flexneri, EHEC, and Helicobacter pylori [20,21,22]. Plant et
al. showed that Neisseria gonorrhoeae causes a 20-fold upregulation of
amphiregulin upon 2 hours of infection [23]. In addition, peptides
derived from amphiregulin have been shown to possess antimi-
crobial activity against several pathogens in vitro [24].
In the present study we investigated amphiregulin in prolonged
infection by N. gonorrhoeae in the human cervical epithelial cell line
Me-180. We show that N. gonorrhoeae up-regulates gene transcrip-
tion of amphiregulin. Further, the proteolytic cleavage pattern of
amphiregulin at the plasma membrane is changed and the
majority of induced amphiregulin is released in the cell
supernatant, followed by a co-localization with the adhered
bacteria at the plasma membrane.
Results
N. gonorrhoeae increases amphiregulin mRNA
Non-confluent epithelial like cervical Me-180 cells were infected
with the piliated strain N. gonorrhoeae MS11 P
+ for 1–72 hours.
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16369Total cell RNA was extracted, and cDNA was synthesized using
eukaryotic-specific oligo-dT primers. Using real time quantitative
polymerase chain reaction (qPCR) with amphiregulin gene specific
primers, we measured the mRNA levels of amphiregulin and the
amphiregulin receptor EGFR in Me-180 cells. An upregulation of
the transcription of amphiregulin mRNA was detected after
infection compared to untreated cells and normalized to
housekeeping gene GAPDH. Increased mRNA levels were seen
already after 1 hour with amphiregulin mRNA more than 3-fold
upregulated. The upregulation peaked after 6 hours of infection
with more than 20-fold increase in amphiregulin mRNA levels
(Figure 1A). No change in transcriptional level was seen for the
EGFR receptor 1–24 hours of infection, as compared to
uninfected control cells (Figure 1A). A minor upregulation was
also seen after 6 hours of infection with the non-piliated N.
gonorrhoeae strain MS11 P
2n and N. lactamica but not with E. coli
(Figure 1B). This data suggests that the upregulation is specific for
pathogenic Neisseria and that major increased transcription of
amphiregulin is associated with bacterial adherence to host cells.
The upregulation was also seen in HEC-1-B cells, with a 15-fold
upregulation of amphiregulin mRNA after 6 hours of gonococcal
infection but not after infection with N. lactamica or E. coli
(Figure 1C). No change in amphiregulin mRNA levels was
detected in vaginal epithelial VK2/E6E7 cells after gonococcal
infection (Figure 1D).
Bacterial infection induces alternative cleavage of
amphiregulin and the product is released into the cell
supernatant
Since mRNA of amphiregulin was upregulated several fold
during infection with N. gonorrhoeae, we then analyzed the protein
expression, cleavage and release upon infection. Under normal
conditions the full-length pro-amphiregulin is cleaved by metallo-
proteases at the plasma membrane and the bioactive domain of
amphiregulin is released in the cell supernatant. To investigate
whether an enhanced release could be seen upon infection with N.
gonorrhoeae, cell culture supernatants from N. gonorrhoeae MS11 P
+
Figure 1. Amphiregulin is upregulated during N. gonorrhoeae infection. Relative amphiregulin mRNA expression was quantified by qPCR.
Relative increase of mRNA in infected cells is presented, after normalization to the reference gene GAPDH. The black bars represent an average of
three independent experiments and standard deviations of relative amphiregulin mRNA expression (* P,0.05). (A) Quantification of amphiregulin
and EGFR mRNA in Me-180 cells at 1, 2, 6, 24, and for amphiregulin and additional time point at 72 hours post infection. The graph shows the relative
change in mRNA levels of Me-180 cells infected with N. gonorrhoeae at different time points. The relative changes in EGFR mRNA are illustrated by the
white bars and represent one single infection for each time point (B) Relative change in mRNA levels of Me-180 cells infected with N. gonorrhoeae
MS11P-n, N. lactamica and E. coli at 6 hours of incubation (C) Relative change in mRNA levels of HEC-1-B cells infected with N. gonorrhoeae MS11 P
+
and MS11P
2n, N. lactamica and E. coli for 6 hours. (D) Relative change in mRNA levels of VK2/E6E7 cells infected with N. gonorrhoeae MS11 P
+ and
MS11P
2n after 6 hours of incubation. The black bars represent an average of two independent experiments and standard deviations of relative
amphiregulin mRNA expression.
doi:10.1371/journal.pone.0016369.g001
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infection. The supernatant was used for coating wells over night
for ELISA assay. A polyclonal antibody against the bioactive part
of amphiregulin was used (MBS220633). Indeed, as shown in
figure 2A there is an increase in amphiregulin protein in the
medium already after one hour of infection with a more than eight
fold increase compared to uninfected samples.
To further study the shedded proteins, the supernatant samples
were analyzed by western blotting with the same antibody. The
increased protein levels seen in figure 2A consisted of two different
cleavage products of amphiregulin. The 28 kDa band represents
the regular release of amphiregulin and did not increase upon
infection. However, at one and two hours of infection an
additional band at 36 kDa appeared (Figure 2B). This additional
Figure 2. N. gonorrhoeae infection induces the release of a 36 kDa product of amphiregulin. Cell culture supernatants from infected cells
and control cells were used to detect released amphiregulin in ELISA and Western blot. Supernatant was separated by SDS-PAGE and
immunoblotted. By using polyclonal antibodies against amphiregulin (MBS220633), followed by secondary IgG antibodies conjugated with IRDye
800cw, the release of the 28 kDa domain was visualized. An additional band of 36 kDa in infected samples was identified and correlates to the
alternative cleavage pattern exclusively induced by the infection. (A) Graph shows an ELISA assay of the release of amphiregulin into the Me-180 cell
supernatants after infection with N. gonorrhoeae MS11 P
+. The graph represents an average of two independent experiments and standard deviations
(* P,0.05). (B) Western blots of Me-180 cell supernatants from 1, 2, and 6 hours incubations in the presence (+) or absence (2)o fN. gonorrhoeae
MS11 P
+.( C) Graphs show the relative release of amphiregulin into the cell supernatants of Me-180 cells infected for 1 hour with MS11 P
2n, N.
lactamica and E. coli (upper left graph), HEC-1-B supernatants of cells infected for 1 hour with indicated strains (upper right graph). The graphs
represent an average of two independent experiments and standard deviations (* P,0.05). Lower graph shows results from one ELISA of
supernatants from VK2/E6E7 cells infected for 1 hour with indicated bacterial strains. (D) Western blots of ME-180 cell supernatants (upper
membrane), HEC-1-B cell supernatants (middle membrane), and VK2/E6E7 cell supernatants (lower membrane) from 1 hour of incubation in the
presence of different bacterial strains.
doi:10.1371/journal.pone.0016369.g002
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amphiregulin processing induced by the infection is different from
regular amphiregulin cleavage in uninfected control.
Also, non-piliated N. gonorrhoeae MS11 P
2n caused an increased
release of amphiregulin, suggesting that this high release is not
dependent on bacterial adherence, but is N. gonorrhoeae-specific.
Further, this is also attributed for HEC-1-B cells and VK2/E6E7
cells. Infection with non-pathogenic gram-negative bacteria
resulted in a lower relative protein release after 1 hour (Figure 2C).
As seen in the western blot, the 36 kDa band released after one
hour from Me-180 cells was specific for N. gonorrhoeae MS11 P
+ and
N. gonorrhoeae MS11 P
2n infections, while no bands were visible in
E. coli infected ME-180 cells (Figure 2D). The 36 kDa product was
not visible after 1 hour of infection in HEC-1-B cells or VK2/
E6E7 cells. However, HEC-1-B cells released very low levels of the
alternatively processed form of amphiregulin after 6 hours of
infection with MS11 P
+ (Figure S1). In supernatant of uninfected
cells, the minor release of amphiregulin was close to the level of the
background signal. The controls with only bacterial suspension
gave no signal, confirming that the products released are not of
bacterial origin.
Taken together, these experiments show that during N.
gonorrhoeae infection amphiregulin is cleaved off from the plasma
membrane and a 36 kDa product is released into the extracellular
media.
The 36 kDa product of amphiregulin is binding to the
plasma membrane and co-localizes with the bacterial
adherence
We investigated the fate of the released products from the
supernatant duringinfection.Me-180 cellswere infected for6 hours
with N. gonorrhoeae MS11 P
+ and fixed but not permeabilized,
resulting in solid plasma membrane bound antibodies against the
bioactive domain of amphiregulin (using antibody MBS220633). As
compared to the uninfected control cells, the infected cells possess
increased plasma membrane staining in immunofluorescence assay
(Figure 3A). Inaddition,thefluorescent stainingof amphiregulinco-
localizes to the site of bacterial adherence, as determined by
Hoechst 33342 staining of bacterial DNA (Figure 3B).
To quantify the increased plasma membrane binding of
amphiregulin, 10 000 cells were counted in flow cytometry assay
using the polyclonal antibody against the bioactive part of
amphiregulin (MBS220633). Data from the flow cytometry
analysis of surface bound protein further show an increase of cells
positive for amphiregulin (Figure 3C). Since the release of
amphiregulin is composed of two products, a 28 kDa bioactive
domain, and a bacterial induced 36 kDa product, it is reasonable
to assume that the increased amphiregulin staining seen is due to
the 36 kDa product.
N. gonorrhoeae changes the subcellular distribution of
the bioactive part of amphiregulin
During the different time points of N. gonorrhoeae infection, we
clearly observed a changed pattern in subcellular localization of
amphiregulin. Upon infection, amphiregulin is shuttled within the
Me-180 cell in a pattern different from uninfected cells (Figure 4
and 5). Protein lysates from infected and non-infected cells were
separated into fractions containing cell plasma membrane, cell
cytoplasm, and cell nuclei (including nuclear membrane and
nucleoplasm). The different fractions of the cells were analyzed in
western blot and by using antibodies against nuclei specific Cyclin
E (Figure S2) and cytoplasmic and membrane located Ezrin
(Figure S3) any cross contamination of the cellular fractions could
be excluded. To analyze the distribution of amphiregulin, the
different subcompartments of the cells were blotted using a
polyclonal antibody against the bioactive part of amphiregulin
(MBS220633). In control cells, four distinct bands representing
different forms of amphiregulin were detected with the sizes of
50 kDa, 43 kDa, 36 kDa, and 19–21 kDa. The 50 kDa and
43 kDa size forms of amphiregulin are also visible in the nuclear
fraction, probably the nuclear membrane, while the 36 kDa and
19–21 kDa bands are found in the cytoplasm (Figure 4). Most
interestingly, the 36 kDa band is present in high concentration in
the plasma membrane fraction of cell lysates, only in infected cells,
which correlates to previous data in figure 3. In addition, the
36 kDa form of amphiregulin is also suddenly present in the
nuclear fraction (Figure 4). At the same time, there is a decrease of
the full-length 50 kDa band only in infected samples, indicating
that the full-length amphiregulin is more extensively processed and
cleaved in infected cells.
In permeabilized and fixed Me-180 cells, amphiregulin can be
detected in the plasma membrane, in the cytoplasm and in the
nuclear membrane or ER when using an antibody directed against
the bioactive domain (MBS220633) of amphiregulin, as visualized
by immunofluorescence (Figure 5). Less amphiregulin staining was
seen in the nucleus, even though having two nuclear localization
sequences (NLS) within the DNA sequence [12]. After 24 hours of
infection, the subcellular localization of the bioactive domain of
amphiregulin was changed from the cytoplasm to the nuclear
membrane. When an antibody specific against the pro-region of
amphiregulin was used (ab48191), a strong and exclusive nuclear
staining appears. This indicates that only the pro-region may have
a reason to localize in the nucleoplasm, and an even stronger
staining for nuclear localization was seen after infection. A similar
pattern with stronger nuclear and cytoplasmic staining after
infection was seen when using an antibody (Z432) directed against
the full-length protein (Figure 5).
Amphiregulin is not used as a receptor for initial bacterial
adherence
Amphiregulin is an abundant cell surface exposed glycoprotein
and has the potential to play a part in bacterial binding to host
cells. Also in the present paper we present data on co-localization
of amphiregulin to the site of adhered bacteria. Therefore, we
investigated the role of amphiregulin during initial bacterial
adherence. Prior to bacterial adherence we blocked the extracel-
lular exposed amphiregulin with polyclonal antibodies for 2 hours.
These antibodies have previously been shown to neutralize the
function of amphiregulin by reducing cell growth [25]. After
neutralization of the amphiregulin, bacterial adherence was
allowed to proceed for 90 minutes. No significant change in
bacterial adherence could be detected, indicating that N. gonorrhoeae
did not use amphiregulin as a cellular receptor for adherence
(Figure 6).
Silencing amphiregulin mRNA expression by short interfering
RNA (siRNA) was unsuccessful. Removal of amphiregulin resulted
in growth arrest as well as reduced cell viability and no bacterial
adherence (data not shown). This is in agreement with previous
report where N. gonorrhoeae MS11 P
+ were shown not to adhere to
non-cycling cells [9].
Discussion
Adhesion and followed invasion of N. gonorrhoeae to host cells is
known to alter expression of a multitude of proteins in host cells.
Amphiregulin has been thoroughly investigated for its role in a
variety of cancers and other proliferative diseases, but not yet for
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PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16369Figure 3. N. gonorrhoeae infection causes an increase of membrane bound amphiregulin that co-localizes with the site of bacterial
adherence. Non-permeabilized Me-180 cells were infected with N. gonorrhoeae for 6 hours. Amphiregulin was detected by using polyclonal
antibodies against amphiregulin (MBS220633), followed by secondary IgG antibodies conjugated with fluorofor Alexa 488 nm. (A) Representative
immunofluorescence images visualizing the protein levels of amphiregulin on the plasma membrane in control cells and infected cells. Cellular DNA
and bacterial DNA was stained with the cell-permeable dye Hoechst 33342. (B) High magnification images of infected Me-180 cells. Image showing
the co-localization between surface bound amphiregulin (red) and bacterial DNA staining (blue). (C) Flow cytometry histogram showing the protein
levels of plasma membrane bound amphiregulin in non-permeabilized cells. Amphiregulin staining on uninfected control cells is shown in grey while
staining of infected cells is shown with a black line. The histogram is representative of two independent experiments.
doi:10.1371/journal.pone.0016369.g003
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infections of N. gonorrhoeae have been associated with proliferative
abnormalities, although very rare [26,27,28]. In the present study
we show that N. gonorrhoeae infection changes the fate of one of the
most abundant of growth factors; amphiregulin. Early bacterial
infection induces amphiregulin mRNA upregulation, alternate
processing and cleavage, subcellular localization and release. The
effects seen are prolonged for at least 24 hours of infection.
Figure 4. The bacterial infection induces an alternative amphiregulin cleavage pattern. Cellular fractions of control cells and infected Me-
180 cells were separated by SDS-PAGE and immunoblotted. By using polyclonal antibodies against amphiregulin (MBS220633), followed by
secondary IgG antibodies conjugated with IRDye 800cw, localization and distribution of amphiregulin cleavage products could be analyzed. Shown
are infections for 2, 6, and 24 hours in the presence (+) or absence (2) of bacteria.
doi:10.1371/journal.pone.0016369.g004
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peptide (Figure 7A). At the plasma membrane, it undergoes
proteolytic cleavage by a specific member of the ADAM family of
proteases, ADAM17, to produce the bioactive domain [10]. The
bioactive domain is a 19–21 kDa (78 or 84 amino acids) product
containing a heparin binding domain and an epidermal growth
factor (EGF) like domain (Figure 7A). After binding of the
bioactive domain to its autocrine receptor, EGFR, additional
events occurs, such as auto-phosphorylation, internalization,
endocytosis and recycling of the receptor [29]. Several predicted
models of the cleavage and release of amphiregulin have been
proposed, and it seems to depend on cell line analyzed and
external conditions [11,14,30].
Here, we propose an adapted model for the amphiregulin
protein processing in Me-180 cells and how it changes during N.
gonorrhoeae infection (Figure 7B). The parts of the protein to which
the different antibodies are directed against, are also illustrated in
Figure 7C. In uninfected control Me-180 cells, amphiregulin is
localized to the cytoplasm, nuclear membrane or ER and a small
amount is also found on the plasma membrane. The main
localization of the bioactive protein was observed in the cytoplasm
in accordance with previous studies in other cell lines [16,31,32].
The cytoplasmic location of bioactive amphiregulin could be
explained by ligation of the receptor that upon binding is
internalized and recycled [29]. In western blot of control cells
amphiregulin was seen as four distinct bands of 50 kDa, 43 kDa,
36 kDa and 19–21 kDa in size. Upon infection an additional band
of 28 kDa appeared. The different domains and cleaved fragments
of amphiregulin have separate fates after shedding from the
membrane and exert different functions on cellular processes. The
larger band of 43 kDa corresponds to the heparin binding domain
and EGF domain in connection with the N-terminus. It is seen in
the nuclear fraction while the lower bands at 36 kDa found in the
cytoplasm represent the same fragment after removal of the signal
Figure 5. Amphiregulin protein expression in Me-180 cells. Permeabilized infected cells and control Me-180 cells stained with antibodies
against different parts of amphiregulin, the bioactive domain (MBS220633), the full-length protein (Z432), and the pro-region of amphiregulin
(ab48191). The binding sites for each of the antibodies used are visualized in figure 7C. Cells were control stained with a-tubulin and Hoechst 33342.
Scale bars are indicated. Images are representative from 3 independent experiments.
doi:10.1371/journal.pone.0016369.g005
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the supernatant. We propose that this 28 kDa band is represented
by the heparin binding domain in connection with the pro N-
terminus (Figure 7B). In the uninfected cells we do not detect any
protein in the plasma membrane fraction on the western blot even
though we see a signal in the fluorescence microscope. This could
be to the fact that only a little protein is found on the surface in un-
stimulated Me-180 cells. The bioactive cleavage product of 19–
21 kDa that could be responsible for EGFR activation on the
plasma membrane, even though other soluble factors of amphir-
egulin containing the EGF domain could also be involved in this
process [11]. In Me-180 cells, we observed a strong signal in
fluorescence microscopy for the N-terminus of amphiregulin in the
nucleoplasm, which was not seen for any of the other domains.
The N-terminus of pro-amphiregulin has been documented to be
required for proper folding and export from the cell since deleted
N-terminal pro-region completely abolished the release of
amphiregulin [30].
After understanding amphiregulin in uninfected control Me-180
cells, we then investigated amphiregulin during bacterial infection
in three different cell lines. We show that the infection by N.
gonorrhoeae MS11 P
+ immediately enhances the transcription of
amphiregulin in ME-180 cells and HEC-1-B cells, but not in
VK2/E6E7 cells. The minor increase in N. lactamica and E. coli
infected cells may be due to toll-like receptor 4 activation via
bacterial lipooligosaccharide (LOS) expression, as has been
reported for intestinal cells [33]. Even though, this is not in
agreement with previous findings where LOS expressing N.
meningitidis did not increase the transcription of amphiregulin after
6 hours of infection [23]. Already after one hour of infection with
MS11 P
+ in Me-180 cells, the mRNA levels increase to high levels.
But a following increase in total protein concentrations does not
occur inside the cell. Upon infection, the majority of the full-length
50 kDa pro-amphiregulin is rather cleaved immediately into a
36 kDa product, exclusively localized to the cytoplasm and
nuclear fraction as determined by western blot. As a consequence,
reduced protein levels of the pro-amphiregulin can be seen. In
addition, these 36 kDa products are released to the cell culture
supernatant and bind to the plasma membrane, most likely to the
EGFR in the infected cells. Amphiregulin functions in an
autocrine manner and the bioactive form (19–21 kDa cleavage
product) is known to bind the EGFR on the outside of the plasma
membrane. An increased release would therefore lead to more
amphiregulin bound to the surface of the Me-180 cells that in turn
leads to a stimulatory response in the cell to upregulate
amphiregulin at 6 hours post infection. As expected, an increased
fluorescent staining of plasma membrane bound amphiregulin in
non-permeabilized cells can be seen after 6 hours of infection. The
staining co-localized with the site of bacterial adherence, which
further proves the binding of amphiregulin to the EGFR,
previously shown to cluster at the cortical plaque formations
underneath the site of adhered bacteria [3]. There is also an
appearance of the 28 kDa factor on the membrane after bacterial
adherence, possibly being the released product binding to the
plasma membrane with its heparin binding domain via heparan
sulfate glycosaminoglycan, which has been shown to act as a co-
receptor for amphiregulin [34]. Alternatively, the 28 kDa band
could be a membrane bound bioactive protein containing also the
transmembrane and cytoplasmic tail domains, formed upon
infection (Figure 7B). Binding of gonococci to cell surface heparan
sulfate proteoglycans has previously been shown to have a role in
the establishment of infection and a member of the opacity (opa)
protein family in N. gonorrhoeae mediates this attachment. This
interaction could be of interest to study further, as it could be part
also of an explanation for the co-localization at the membrane, but
has not been the focus of this work where an opa-negative strain
has been used.
The bi-functional role of amphiregulin as a growth regulator in
Me-180 cells during N. gonorrhoeae infection will be under further
investigation. Interfering with host epithelial layer probity and
modifying cellular growth at the cervical mucosa will most likely
favor bacterial infection, intracellular survival and disease
progression. A cell with impaired growth reduces both the
protection of the mucosal barrier, its integrity and repair
mechanisms as well as inflammatory responses and defense
mechanisms. The data presented in this work highlights the
importance of studying the role of the pathogenic bacterium N.
gonorrhoeae in the regulation of host cell growth and proliferation by
modifying targets such as the major epidermal growth factor
amphiregulin.
Materials and Methods
Cell line and bacterial strain
Me-180 (ATCC HTB33) epithelial-like cell line from cervical
carcinoma was maintained in DMEM supplemented with 10%
inactivated fetal bovine serum (FBS) (Invitrogen) at 37uC, 5%
CO2. HEC-1-B (ATCC HTB 113) human endometrial adeno-
carcinoma cell line were maintained in Eagle minimal essential
medium supplemented with 10% FBS at 37uC, 5% CO2. VK2/
E6E7 (ATCC CRL-2616) human epithelial vaginal cells were
maintained in keratinocyte-serum free medium (Invitrogen)
supplemented with 0.1 ng/ml human recombinant EGF,
0.05 mg/ml bovine pituitary extract and 44.1 mg/l calcium
chloride, all purchased from Invitrogen. N. gonorrhoeae adheres
and invades VK2/E6E7 cells [35]. All cell lines were sub-cultured
2–3 times per week and never grown to high confluence. Cells
Figure 6. Amphiregulin is not used as a receptor for N.
gonorrhoeae. The graph shows a bacterial binding assay to Me-180
cells. Cells were pretreated neutralizing, polyclonal antibody AF262
prior to assay. Bacterial adherence was allowed for 1.5 hours, unbound
bacteria were washed away, and adherent bacteria were counted the
next day. Shown is an average of 3 independent experiments and
standard deviations (P,0.05). Percentage of bacterial adherence is
presented. A 100% adherence corresponds to 40–60 adherent bacteria
per Me-180 cell.
doi:10.1371/journal.pone.0016369.g006
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gonorrhoeae strain MS11mk (P+) [36] is referred in the text to
MS11 P
+. Piliated, Opa-negative phenotypes were used in assays,
as distinguished by colony morphology and opacity under
binocular light microscope. The N. gonorrhoeae MS11 P
2n variant
harbors a deletion at the 59 end of pilE gene resulting in a non-
piliated phenotype [36]. Non-pathogenic N. lactamica properties
have been described previously [37]. The bacteria were grown on
GC medium base (Difco) agar plates containing Kellogg’s
supplement [38] at 37uC, 5% CO2. Piliated, Opa-negative
bacteria were selected and sub-cultured every 18–24 hours. The
E. coli strain DH5a were grown on LB agar plates (BD Biosciences)
at 37uC and 5% CO2.
Bacterial infection of cells
Upon assay, 18–24 hours old bacteria were harvested from the
plates in sterile phosphate buffered saline (PBS). The number of
bacteria was calculated by measuring the absorbance at 600 nm
wavelengths. Optical density was adjusted to 1, which equals
5610
8 bacteria per milliliter. Bacteria were added to a non-
Figure 7. N. gonorrhoeae induces alternative processing and release of amphiregulin. (A) Pro-amphiregulin is synthesized by 252 amino
acids (50 kDa). The protein consists of a signal peptide, a N-terminal pro-region, a heparin binding domain, an EGF-like domain, a transmembrane
domain, and a cytoplasmic domain. Due to metalloprotease dependent cleavage, amphiregulin can produce several products with the molecular
sizes 50, 43, 36, 28, and 19–21 kDa. (B) Schematic illustration of amphiregulin expression, cleavage pattern and processing in Me-180 cells. N.
gonorrhoeae infection changes the cleavage pattern, subcellular localization, processing, and release of amphiregulin in Me-180 cells. (* Indicates
alternative fate of cleaved amphiregulin [11].) (C) Illustration of the recognition sites of the antibodies used in this study.
doi:10.1371/journal.pone.0016369.g007
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(MOI) of 100. The infection was allowed to proceed for 1–
72 hours in 37uC, 5% CO2. For longer assays, unbound bacteria
were carefully washed away with DMEM after 2 hours, 10 hours
and 24 hours to prevent overgrowth in the cell culture medium.
Through out all experiments, uninfected control cells were treated
equally in terms of incubation and washing procedures, ensuring
that the only difference between the control and samples were
specific to the gonococcal infection.
Quantitative real time PCR analysis
RNA from control cells and infected Me-180 cells was isolated
with the RNeasy Mini kit according to manufacturers recommen-
dations (Qiagen). Total RNA (up to 1 mg) was reverse transcribed
using Superscript III First strand synthesis supermix (Invitrogen),
using oligo-dT primers according to manufacturers recommenda-
tions. Primers used were: Amphiregulin (forward 59-GTGGTG-
CTGTCGCTCTTGATACTC-39 and reversed 59-TCAAATC-
CATCAGCACTGTGGTC-39), EGFR (forward 59- ACTGCAC-
CTACGGATGCACTGG-39 and reversed 59- AACGATGTG-
GCGCCTTCGCA-39), and GAPDH (forward 59TCGTCATG-
GGTGTGAACCATGAGA-39, reversed 59TGTGGTCATGAG-
TCCTTCCACGAT-39). PCR amplification was performed using
a LightCycler 480 (Roche) and SYBRGreenI Master kit (Roche)
with 0.1 mM of each gene specific primer and 1 ml of cDNA. PCR
program was as follows: initial denaturation for 300 s, amplifica-
tion for 40 cycles with denaturation at 95uC for 20 s, annealing at
60uC for 15 s and extension at 72uC for 15 s. The transition rate
was 2.2–4.4uC/s. Melting curve analysis was conducted in three
segments: 95uC for 5 s, 70uC for 60 s and then increasing to 95uC.
The transition rate was 2.2–4.4uC/s for the first and second
segment and 0.19uC/s for the last segment. Concentrations of
mRNA of amphiregulin and EGFR were analyzed and compared,
using GAPDH as an internal standard. Expression ratios were
calculated, normalized, and compared between control cells and
infected cells.
Antibodies
The monoclonal antibody Z432 (Santa Cruz) was raised against
amphiregulin full-length protein and was used in immunofluores-
cent assays with a concentration of 10 mg/ml (exact binding
position is not known). The polyclonal antibody ab48191 (Abcam)
against the N-terminal region of the pro-peptide amphiregulin was
used in immunofluorescent assays with a concentration of 3 mg/
ml. The polyclonal antibody MBS220633 (Mybiosource) was
raised against amino acids 108–126 of the bioactive domain of
amphiregulin. MBS220633 was used at concentrations of 20 mg/
ml for western blotting, immunofluorescence, ELISA assay and
flow cytometry. The polyclonal neutralizing and inhibiting
antibody AF262 (R&D systems) was raised in goat against amino
acid 101–198 of amphiregulin. AF262 was used at the concen-
tration of 25 mg/ml and has previously show good neutralizing
capacities [25]. The Secondary antibodies goat-anti mouse IgG –
Alexa 488 or goat-anti rabbit IgG –Alexa 488 was used at
concentrations; 2–4 mg/ml for immunofluorescence and flow
cytometry. In western blot, secondary antibodies goat-anti mouse
IgG –IRDye 800 cw (Licore) or goat-anti rabbit IgG –IRDye 800
cw (Licore) were used at concentrations 0.1 mg/ml. In ELISA,
secondary antibodies goat-anti rabbit IgG –HRP (Bio-Rad) was
used at concentrations 0.4 mg/ml. None of the antibodies directed
against amphiregulin cross-reacted against any bacterial proteins.
Control immunoblots were made of the cell fractionations using a
monoclonal antibody against Ezrin (sc-32759, Santa Cruz) at a
concentration of 0.4 mg/ml and a monoclonal antibody against
Cyclin E (HE-12, Zymed) at 0.5 mg/ml. Control immunofluores-
cent stainings were made by rabbit anti a-tubulin antibodies
(MBS316320, Mybioscource) at 30 mg/ml or mouse anti a-tubulin
antibodies (TUB-1A2, Sigma) 50 mg/ml.
Fluorescence microscopy
Me-180 cells were cultured on 1% metasilicate coated cover
glass slips (Merck, 13 mm, 0.17 mm thick) over night to produce
50–60% of confluence. Cells were infected with a MOI of 100 of
N. gonorrhoeae MS11 P
+ for 6 hours and 24 hours. Cells were
fixated with 4% paraformaldehyde (Sigma) for 10 minutes in room
temperature, washed with PBS, and permeabilized for 5 minutes
in 0.1% NP-40, 20 mM TrisHCl (pH 7.4), 50 mM NaCl,
300 mM Sucrose, and 3 mM MgCl2. Then, cells were washed
carefully in PBS and blocked with 3% bovine serum albumin
(BSA). Cells were stained with the different antibodies against
amphiregulin for 45 minutes. Secondary antibodies were added
for 45 minutes after washing three times with PBS containing
0.01% Tween 20 (Sigma). Non-permeabilized cells were fixated
with 4% paraformaldehyde (Sigma) for 10 minutes in room
temperature, washed with PBS (no Tween 20 added). Glasses were
mounted in Vectashield containing Hoechst 33442 DNA stain
(Vector laboratories Inc, Burlingame, CA, USA). The cells were
imaged using a Zeiss fluorescence microscope.
ELISA
Cells were infected with a MOI of 100 of N. gonorrhoeae MS11
P
+ f o r1 ,2 ,a n d6h o u r s ,o rw i t hN. gonorrhoeae MS11 P
2n, N.
lactamica,o rE. coli for 1 and 6 hours (MOI 100). Cell culture
supernatants from uninfected and infected cells were collected
and treated with Complete mini protease inhibitors mix
(Roche) to avoid protein degradation. DMEM treated the
same way and with or with out added bacterial suspension,
were used as controls to exclude any possible cross reactions
with bacterial products. Immunoplates (Maxisorp 96 well,
Nunc) were coated in triplicates with 0.1 ml samples (diluted in
carbonate buffer) at 4uC over night. The wells were blocked
with 0.2 ml 1% BSA (Sigma) for 2 hours, washed and
amphiregulin was detected with the antibody MBS220633
against amphiregulin (diluted in 1% BSA in PBS) followed by
incubation with HRP conjugated anti-IgG antibodies. For
enzymatic color development, 0.1 ml TMB (Invitrogen) was
added and then 1 M HCl to stop the reaction. The absorption
was read at 450 nm wavelengths.
Western blot analysis
Cells were infected with a MOI of 100 of N. gonorrhoeae MS11 P
+
for 2, 6, and 24 hours. Infected cells and control cells were
carefully washed three times in PBS and then harvested on ice by
addition of SDS reducing sample buffer (87% glycerol, 10% SDS,
0.5 M Tris-HCl pH 6.8, 0.1% bromphenol blue) and immediately
stored at 220uC until use. Samples were incubated at 95uC for
10 min and 5 ml was loaded onto a 12% gel for SDS-PAGE
according to manufacturers recommendations (Bio-Rad) After
separation, proteins in the gel were transferred to PVDF
membranes (Milli-Pore) using semidry transfer system (Bio-Rad).
The membranes were washed in water and blocked overnight at
4uC in 5% nonfat dry milk (Bio-Rad) diluted in PBS. The
membranes were incubated in room temperature, agitating with
the MBS220633 antibody against amphiregulin for 45 min.
Incubation with secondary antibody goat anti-rabbit IRDye
800cw was performed for 45 min. Bands were visualized using
Odyssey infrared imaging system (Li-Core).
Amphiregulin Processing in N.gonorrhoeae Infection
PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16369Flow cytometry assay
Cells were infected with a MOI of 100 of N. gonorrhoeae MS11 P
+
for 6 hours. Infected cells and control cells were carefully washed
three times in PBS and then harvested by trypsination (Trypsin/
EDTA, Invitrogen). Cells were washed in PBS by centrifugation at
10006g for 10 minutes, and fixed with 4% paraformaldehyd for
10 minutes in room temperature. Cells were stained with the
antibody MBS220633 against amphiregulin for 45 minutes.
Secondary Alexa 488 nm conjugated antibodies were added for
45 minutes after washing three times with PBS. The flow
cytometry device counted 10 000 cells for fluorescence (FACScan).
Cell fractionations
Cells were infected with a MOI of 100 of N. gonorrhoeae MS11 P
+
for 2, 6, and 24 hours. Infected cells and control cells were
carefully washed three times in PBS and then scraped off the
culture dish and collected in an eppendorf tube. The cells were
centrifuged at 10006g for 10 minutes at 4uC and the pellets were
permeabilized in 100 ml 0.2% Igepal/protease inhibitor mix/PBS
on ice for 5 minutes. The suspension was forced through a pipette
tip to break the membranes. The nuclear fraction was separated
from the membrane and cytoplasm by centrifugation at 10006g
for 10 minutes at 4uC. Spinning at 1106g for 30 minutes at 4uC
separated the membrane and cytoplasmic fractions. The nuclear
fraction was once washed in cold PBS and centrifuged at 29006g
for 10 minutes at 4uC. The nuclei were resuspended in cold PBS
with a 29-gauge needle to break the nuclear membranes. The
solution was treated with DNase (Promega) for 5 minutes at room
temperature. SDS reducing sample buffer was added to all
fractions and samples were stored at 220uC immediately until
further use.
Bacterial adherence assay
Cells were infected with a MOI of 100 of N. gonorrhoeae MS11 P
+
for 2 hours. Infected cells and control cells were carefully washed
three times in PBS and bacteria were harvested by addition of 1%
saponin for 5 minutes, serially diluted and spread onto GCB-
plates. Plates were incubated over night at 37uC, 5% CO2 and
colony forming units (c.f.u.) were counted the following day.
Antibody inhibition of amphiregulin was performed by a pre
incubation of cells in 25 mg/ml of an inhibiting amphiregulin
antibody raised in goat (AF262) for 1.5 hours prior addition of
bacteria.
Statistical analysis
Released AREG in ELISA assay and bacterial adherence assays
were evaluated using a two-tailed Student’s t test. Values of
P,0.05 were considered significant. For quantitative PCR
analysis, One-way ANOVA (P,0.05) (VasserStats, NY, U.S.A)
was used to compare values between infected cells and uninfected
control cells.
Supporting Information
Figure S1 Immunoblot of cell supernatants after 6
hours of infection. Western blots of ME-180 cell supernatants
(upper membrane), HEC-1-B cell supernatants (middle mem-
brane), and VK2/E6E7 cell supernatants (lower membrane) from
6 hour of incubation in the presence of different bacterial strains.
(EPS)
Figure S2 Cyclin E is localised in the nucleus fraction.
Control immunoblot of cell fractionations. Fractions of Me-180
cell membrane, cytoplasm and nuclei were separated by SDS-
PAGE and immunoblotted using antibodies specific against
proteins expressed in these cell compartments. Secondary
antibodies goat-anti IgG IRDye 800cw were used. Cyclin E is
expressed in the nucleus.
(EPS)
Figure S3 Ezrin is localised in the cytoplamic fraction.
Control immunoblot of cell fractionations. Fractions of Me-180
cell membrane, cytoplasm and nuclei were separated by SDS-
PAGE and immunoblotted using antibodies specific against
proteins expressed in these cell compartments. Secondary
antibodies goat-anti IgG IRDye 800cw were used. Ezrin is
expressed in the cytoplam.
(EPS)
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